Exelixis | EXEL - Ebit

股票价格
47.78
每天变化
1.57 3.40%
每月一次
5.22%
每年
32.10%
Q2 预测
42.77


金融业
股票价格
USD
资产
USD 2.84B
现金及等价物
USD 482.49M
销售成本
USD 19.95M
流动资产
USD 1.44B
流动负债
USD 405.64M
债务
USD 173.04M
EBIT
USD 251.34M
EBITDA
USD 242.86M
员工
1.15K
EPS每股收益
USD 0.87
股本和储备
USD 2.16B
销售毛利
USD 590.86M
债务利息支出
USD 23.4M
利息收入
USD 17.43M
市值
USD 13.6B
净收入
USD 244.53M
营业费用
USD 359.47M
营业利润
USD 251.34M
普通股股本
USD 262.48M
PE价格收益
602.31
税前利润
USD 267.69M
销售收入
USD 610.8M
销售和管理费用
USD 139.6M
股票
USD 21.69M
贸易债权人
USD 29.62M
应收帐款人
USD 286.92M


Ebit 更改 日
Acadia Pharmaceuticals USD -4.62M 22.01M 2026-03
Agios Pharmaceuticals USD -110.02M 11.55M 2026-03
Akebia Therapeutics USD -5.45M 9.4M 2025-12
Amgen USD 3.83B 130M 2026-03
AstraZeneca USD 7.11B 4.14B 2026-03
Bayer EUR 1.11B 1.51B 2025-12
BioMarin Pharmaceutical USD 129.65M 68.74M 2026-03
Bristol-Myers Squibb USD 3.56B 90M 2026-03
Cytokinetics USD -181.23M 2.86M 2026-03
Eisai JPY 20.03B 6.36B 2025-12
Eli Lilly USD 9.78B 792M 2026-03
Esperion Therapeutics USD 85.23M 95.19M 2025-12
Exelixis USD 251.34M 15.43M 2026-03
Genmab DKK 260M 199M 2025-12
Glaxosmithkline GBP 2.3B 1.46B 2025-12
Incyte USD 344.17M 39.71M 2026-03
Ionis Pharmaceuticals USD -118M 97M 2026-03
MacroGenics USD -12.1M 32.26M 2025-12
Merck USD -1.88B 8.12B 2026-03
Moderna USD -1.39B 531M 2026-03
Nektar Therapeutics USD -19.09M 15.26M 2025-12
Neurocrine Biosciences USD 214.6M 13.3M 2026-03
Novartis USD 4.18B 118M 2026-03
Pfizer USD 4.99B 340M 2026-03
Puma Biotechnology USD -2.2M 11.41M 2024-06
Sanofi EUR 3.74B 2.23B 2025-09
Takeda JPY 257.49B 568.56B 2025-12
Ultragenyx Pharmaceutical USD -216M 102M 2026-03
Xencor USD -77.86M 24.23M 2026-03